3 free views remaining today

X-linked agammaglobulinemia

Description

X-linked agammaglobulinemia (XLA) is a genetic condition that affects the immune system, making it difficult for the body to fight off infections.

Key Characteristics:

  • Immune System Disorder: XLA is an inherited disorder that makes it hard for the body to produce enough antibodies, which are proteins that help fight off illnesses.
  • Genetic Cause: The mutated gene responsible for XLA codes for the protein Bruton tyrosine kinase (BTK), and is located on the X chromosome.
  • Primarily Affects Males: XLA occurs almost exclusively in males, as they have only one X chromosome. Females can be carriers of the disease-causing gene but are less likely to develop symptoms themselves.

Symptoms:

  • Recurrent infections of the inner ear, sinuses, respiratory tract, bloodstream, and internal organs
  • Difficulty fighting off illnesses due to low antibody production

Other Facts:

  • XLA is also known as Bruton type agammaglobulinemia or congenital agammaglobulinemia.
  • Early diagnosis and treatment can often lead to a normal life span, unless brain infections develop.

References:

  • [1] X-linked agammaglobulinemia (a-gam-uh-glob-u-lih-NEE-me-uh), also called XLA, is an immune system disorder that's passed through families, called inherited. XLA makes it hard to fight infections.
  • [3] Description. X-linked agammaglobulinemia (XLA) is a condition that affects the immune system and occurs almost exclusively in males.
  • [4] XLA is also called Bruton type agammaglobulinemia, X-linked infantile agammaglobulinemia, and congenital agammaglobulinemia.
  • [6] X-linked agammaglobulinemia increases the risk of developing infections in the joints (infectious arthritis), irreversible widening due to chronic inflammation of the airways (bronchiectasis), and certain cancers.

Additional Characteristics

  • X-linked agammaglobulinemia (XLA) is a genetic condition that affects the immune system, making it difficult for the body to fight off infections.
  • XLA is an inherited disorder that makes it hard for the body to produce enough antibodies, which are proteins that help fight off illnesses.
  • XLA occurs almost exclusively in males, as they have only one X chromosome. Females can be carriers of the disease-causing gene but are less likely to develop symptoms themselves.
  • XLA is also known as Bruton type agammaglobulinemia or congenital agammaglobulinemia.
  • Early diagnosis and treatment can often lead to a normal life span, unless brain infections develop.

Signs and Symptoms

Common Signs and Symptoms of X-linked Agammaglobulinemia

X-linked agammaglobulinemia (XLA) is a genetic disorder that affects the immune system, making it difficult for individuals to fight off infections. The symptoms of XLA can vary from person to person, but here are some common signs and symptoms:

  • Ear Infections: One of the most common symptoms of XLA is recurring ear infections, which can lead to hearing loss if left untreated.
  • Sinusitis: Sinus infections are another frequent symptom of XLA, causing discomfort, pain, and difficulty breathing.
  • Pneumonia: People with XLA are prone to pneumonia, a serious lung infection that requires prompt medical attention.
  • Diarrhea from the parasite Giardia: Some individuals with XLA may experience diarrhea caused by the parasitic infection Giardia.
  • Recurring Coughs and Infections: Infants with XLA often start experiencing recurring coughs and infections of the nose, ears, skin, sinuses, and lungs around 6 months old.

Other Possible Symptoms

In addition to these common symptoms, some individuals with XLA may experience:

  • Vitiligo: A rare symptom of XLA is vitiligo, a condition characterized by white patches on the skin.
  • Erythematous Rash: Some people with XLA may develop an erythematous rash, which can be itchy and uncomfortable.
  • Alopecia Totalis: In rare cases, individuals with XLA may experience alopecia totalis, a condition where all hair falls out.

Important Note

It's essential to consult a physician for a proper diagnosis, as the symptoms of XLA can resemble other medical conditions. A healthcare professional will be able to provide an accurate diagnosis and recommend appropriate treatment.

References:

  • [3] - Symptoms may include...
  • [8] - What are the signs and symptoms of X-linked agammaglobulinemia (XLA)? · Ear infections · Sinusitis · Pneumonia · Diarrhea from the parasite Giardia.
  • [13] - Symptoms of X-Linked Agammaglobulinemia For about the first 6 months after birth, immunoglobulins from the mother protect against infection. At about age 6 months, levels of these immunoglobulins start to decrease, and affected infants start having recurring cough, nasal infections (rhinitis), and/or infections of the ears, skin, sinuses, and ...
  • [14] - Rare patients are reported to have vitiligo, erythematous rash, or alopecia totalis. Infections tend to persist throughout adulthood. Affected patients are ...

Additional Symptoms

Diagnostic Tests

Diagnostic Tests for X-linked Agammaglobulinemia

X-linked agammaglobulinemia (XLA) is a genetic disorder that affects the immune system, making it difficult to diagnose. However, several diagnostic tests can confirm the presence of this condition.

  • Blood Tests: Blood tests are essential in diagnosing XLA. They measure immunoglobulin levels, including IgG, IgM, and IgA, which are crucial for fighting infections (1, 6, 10). Low levels of these immunoglobulins can indicate XLA.
  • Genetic Testing: Genetic testing is used to confirm the diagnosis of XLA by detecting mutations in the BTK gene or measuring the absence of BTK protein in monocytes or platelets (7, 8).
  • Lymphocyte Flow Cytometry: This test measures the number of B cells and T cells in the blood. In individuals with XLA, there is often a reduced or absent B-cell count (11, 12).
  • Immunoglobulin Levels: Measuring immunoglobulin levels, such as IgG, IgM, and IgA, can help diagnose XLA. Low levels of these immunoglobulins are characteristic of this condition (2, 4, 9, 10).

Diagnostic Process

The diagnostic process for XLA involves a thorough evaluation of the patient's medical history, physical examination, and various laboratory tests (14). Early diagnosis is crucial in developing an appropriate treatment plan.

References:

  1. [1] Blood tests can confirm the diagnosis of X-linked agammaglobulinemia.
  2. [2] Recurrent bacterial infections are a common symptom of XLA.
  3. [4] XLA is characterized by low immunoglobulin levels and absent B cells.
  4. [6] Measuring IgG, IgM, and IgA levels can help diagnose XLA.
  5. [7] Genetic testing confirms the diagnosis of XLA.
  6. [8] Blood tests measure immunoglobulin levels and the number of B cells.
  7. [9] A complete medical history and physical examination are essential in diagnosing XLA.
  8. [10] Low immunoglobulin levels and absent B cells confirm the diagnosis of XLA.
  9. [11] Lymphocyte phenotyping using flow cytometry documents an absent or reduced B-cell count.
  10. [12] Transient neutropenia may also be present in individuals with XLA.
  11. [13] Understanding regional differences in presentation and complications is crucial in diagnosing XLA.
  12. [14] A thorough evaluation of the patient's medical history, physical examination, and laboratory tests confirms the diagnosis of XLA.

Treatment

Treatment Overview

X-linked agammaglobulinemia (XLA) is a genetic disorder that impairs the immune system's ability to produce antibodies, making it difficult for individuals with this condition to fight off infections. While there is no cure for XLA, treatment aims at boosting the immune system and preventing infections.

Drug Treatment

The primary goal of drug treatment in XLA is to replace the missing antibodies and prevent infections. The following medications are commonly used:

  • Intravenous Immunoglobulin (IVIG): IVIG is a type of antibody replacement therapy that is administered intravenously into the bloodstream. It provides the necessary antibodies to help fight off infections. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks [5].
  • Antibiotics: Antibiotics such as amoxicillin and amoxicillin/clavulanate are commonly used to treat bacterial infections that may occur in individuals with XLA [8]. Fluoroquinolone therapy is also useful for respiratory tract infections.
  • Gamma Globulin Therapy: Gamma globulin therapy, administered intravenously or subcutaneously, provides the necessary antibodies to help protect against infections [7].

Treatment Goals

The primary goals of drug treatment in XLA are:

  • To prevent infections and their complications
  • To improve quality of life for individuals with XLA
  • To reduce the frequency and severity of infections

References

[5] May 13, 2024 — Treatment for XLA is IVIG. Typical doses are 400-600 mg/kg/mo given every 3-4 weeks. [7] Antibody replacement: Gamma globulin therapy, administered intravenously, will give your child the antibodies he cannot make himself, in order to protect ... [8] May 13, 2024 — Drugs, such as amoxicillin and amoxicillin/clavulanate, are typical agents used. Fluoroquinolone therapy is useful for respiratory ...

Differential Diagnosis

Differential Diagnoses for X-linked Agammaglobulinemia

X-linked agammaglobulinemia (XLA) is a rare inherited immunodeficiency disorder that can be challenging to diagnose. The differential diagnosis for XLA includes several conditions that present with similar symptoms, such as recurrent infections and low antibody levels.

Common Differential Diagnoses:

  • Common Variable Immunodeficiency (CVID): CVID is a primary immunodeficiency characterized by impaired B cell function, leading to low antibody levels. It can present with similar symptoms to XLA, including recurrent infections.
  • Transient Hypogammaglobulinemia of Infancy (THI): THI is a condition that presents with low antibody levels in infants, often resolving on its own within the first two years of life. However, it can be challenging to distinguish from XLA, especially if the infant's symptoms persist.
  • Autosomal-Recessive Agammaglobulinemia: This is a rare form of agammaglobulinemia that presents with low or absent antibody levels and is inherited in an autosomal-recessive pattern.

Other Conditions:

  • Myelodysplasia: Myelodysplasia is a group of disorders characterized by abnormal development of blood cells. It can present with similar symptoms to XLA, including recurrent infections.
  • Congenital Infections: Certain congenital infections, such as rubella or cytomegalovirus, can also present with low antibody levels and recurrent infections.

Key Points:

  • A careful investigation is necessary to rule out these differential diagnoses and confirm a diagnosis of X-linked agammaglobulinemia.
  • Genetic testing can help confirm the diagnosis of XLA by detecting mutations in the BTK gene.
  • Low immunoglobulin levels and absent B cells are key diagnostic features of XLA.

References:

  • [11] - This condition is often challenging to differentiate from other conditions clinically; thus, a careful investigation should be performed to rule them out.
  • [7] - The differential diagnosis for hypogammaglobulinemia includes the following conditions: 1. Common Variable Immune Deficiency (CVID) 2. Autosomal recessive agammaglobulinemia
  • [9] - Differential diagnoses include X-linked agammaglobulinemia in male patients, myelodysplasia or congenital infections.
  • [13] - Low immunoglobulin levels and absent B cells are key diagnostic features of XLA.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
rdf-schema#comment
OMIM mapping confirmed by DO. [SN].
oboInOwl#id
DOID:14179
core#notation
DOID:14179
oboInOwl#hasDbXref
UMLS_CUI:C0221026
oboInOwl#hasExactSynonym
BTK deficiency
rdf-schema#label
X-linked agammaglobulinemia
IAO_0000115
An agammaglobulinemia that is that has_material_basis_in a mutation in the Bruton's tyrosine kinase (BTK) gene on the X chromosome resulting in X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement.
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
t408745
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_8834
owl#annotatedSource
t408393

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.